http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5196416-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
| filingDate | 1991-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d55a1eb8b590342be9116590a9ed1fa |
| publicationDate | 1993-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5196416-A |
| titleOfInvention | Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water |
| abstract | Permeation enhancement compositions are disclosed. Said compositions include from 30 to 70 parts by weight ethanol, from 0.1 to 10 parts by weight azone, from 30 to 80 parts by weight water and optionally from 10 to 30 parts by weight propylene glycol, which compositions provide increased percutaneous absorption of a pharmacologically active agent disposed therewith. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112057435-A |
| priorityDate | 1987-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.